Alivira Animal Health Ltd, established in 2013, is India's largest and first global integrated animal health company specializing in the manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF). With a presence in over 100 countries, Alivira operates eight manufacturing facilities across India, Spain, Germany, Brazil, and Turkey, all approved by top global regulatory bodies, including USFDA, EUGMP, WHO, and TGA. The company offers a comprehensive portfolio across formulations, animal health APIs, and provides analytical services to the pharmaceutical and life sciences industry. Alivira is a 100% subsidiary of Sequent Scientific Limited, a company listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in India.